Genetic engineering is a significant tool for scientists. Genes and other genetic evidence from a wide range of organisms are converted into bacteria, creating genetically modified bacteria in the procedure. The introduction of new DNA does not require the usage of classical genetic methods; however traditional breeding methods are typically used for the proliferation of recombinant organisms. An organism that is produced through the introduction of recombinant DNA is known to be a genetically modified organism. The first organisms genetically engineered were bacteria in 1973 and then mice in 1974.

Genetic Engineering is getting importance because of its use in different arenas. In medicine genetic engineering has been used to mass-produce insulin, human growth hormones, follistim (for treating infertility), human albumin, monoclonal antibodies, antihemophilic factors, vaccines and many other drugs.

GLOBAL GENE EDITING MARKET:

Gene Editing Market size valued at USD 3.8 billion in 2019 and is expected to witness 14.9% CAGR from 2020 to 2026. Increasing advancements in gene editing technologies are anticipated to boost the market demand.